Jc. Oates et al., EFFECT OF LATE MODULATION OF NITRIC-OXIDE PRODUCTION ON MURINE LUPUS, Clinical immunology and immunopathology, 83(1), 1997, pp. 86-92
MRL/MpJ-Fas(lpr) (MRL-lpr) and New Zealand Black/White (NZB/W) mice de
velop spontaneous autoimmune disease characterized by autoantibody pro
duction and glomerulonephritis that progresses in parallel with increa
sing systemic nitric oxide (NO) production. A previously published stu
dy from our laboratory indicated that oral administration of the nitri
c oxide synthase inhibitor N-G-monomethyl-L-arginine (NMMA) before the
onset of clinical disease significantly decreased renal and joint pat
hology in MRL-lpr mice, To characterize the effect of late modulation
of NO production in murine SLE, we administered oral NMMA and/or restr
icted dietary arginine after disease onset in two murine models of SLE
. When receiving combined NMMA and arginine restriction, MRL-Epr mice
had reduced joint pathology scores and NZB/W mice had lower renal path
ology scores than control mice. These results indicate that modulating
NO production after the onset of disease diminishes disease severity
in two models of SLE, although not as effectively as treating before d
isease onset. (C) 1997 Academic Press.